Small and large investors in dividend stocks can use covered calls and puts trades to generate monthly income from options premiums and options trading
8.11.23. XOM $111.64. Sold XOM 8.25.23 (14 days) $107 puts for $1.10. ARoR about 25%. Delta -.30, OTM 68%, IV 23.7%. M* 3*, FVE $118. Analysts high target price $145, Mean $125.94, Low $107. Average analyst rating 3.78, moderate buy. Barchart 8%, or weak, buy rating. My XOM 8.18.23 $111 calls may be called next week before it goes ex dividend on 8.15.23.
8.11.23. I bought back my IWM 8.11.23 $189 puts for $.07 just in case the markets tank on the close.
My QQQ 8.11.23 $368 puts are in the money. I think I'll take the QQQ shares and write covered calls on them Monday. The goal, over time, is to sell ATM and later OTM calls at strikes that will let me break even or make a profit on the trade.
I'm waiting until Monday to see how the dip is going before doing anything else.
8.8.23. Sold DHR 8.18.23 (17 days) $240 puts for $0.85. ARoR about 7.11%. 48% buy rating. TP H $325, MEAN $288, L $240. CrossingWallStreet.com buy below $270. Analysts, strong buy rating is 4.58. 50 dma $242. M* 3* FVE is $265. Annual dividend on net debit of $239.150 is about 0.452%.
8.11.23. XOM $111.64. Sold XOM 8.25.23 (14 days) $107 puts for $1.10. ARoR about 25%. Delta -.30, OTM 68%, IV 23.7%. M* 3*, FVE $118. Analysts high target price $145, Mean $125.94, Low $107. Average analyst rating 3.78, moderate buy. Barchart 8%, or weak, buy rating. My XOM 8.18.23 $111 calls may be called next week before it goes ex dividend on 8.15.23.
8.11.23. I bought back my IWM 8.11.23 $189 puts for $.07 just in case the markets tank on the close.
My QQQ 8.11.23 $368 puts are in the money. I think I'll take the QQQ shares and write covered calls on them Monday. The goal, over time, is to sell ATM and later OTM calls at strikes that will let me break even or make a profit on the trade.
I'm waiting until Monday to see how the dip is going before doing anything else.
8.10.23. MRNA $101.37. Sold MRNA 8.25.23 (15 days) $91 puts @ $0.58. ARoR about 13.9%.
Morningstar.com home page touts MRNA as 60% undervalued. M* 5*, FVE $266. Barchart 100% sell rating. Analysts give MRNA moderate buy rating of 3.69. Analysts hit target price $430, Mean $181.72. Low $82.
8.9.23. WSM $138.61. S WSM 8.25.23 (16 days) $121 strike puts for $0.75. ARoR about 11%. Delta -.10, OTM 88%, IV 49.7%. Analysts' rating a weak 2.61. High target price $146, Mean $120, Low $95. M* FVE $209. 4*. Buychart.com strong 88% buy rating.
8.8.23. Sold DHR 8.18.23 (17 days) $240 puts for $0.85. ARoR about 7.11%. 48% buy rating. TP H $325, MEAN $288, L $240. CrossingWallStreet.com buy below $270. Analysts, strong buy rating is 4.58. 50 dma $242. M* 3* FVE is $265. Annual dividend on net debit of $239.150 is about 0.452%.
8.7.23. JEPI $55.43. I sold JEPI 8.18.23 (11 days) $55 puts for $0.13/share. Delta -.25. OTM 74.8%. IV 8.3%. ARoR about 7.782%.
XLE $87.15. Sold XLE 8.18.23 (11 days) $84 puts for $0.38/share. Delta -.18. OTM 80.6%. IV 25.6%. ARoR about 13%.